Abstract: Disclosed is a composition for inducing the proliferation of retinal cells or the differentiation of retinal progenitor cells into retinal cells. The composition, similar to in vivo conditions for development during embryogenesis, induces stem cells to differentiate into a multitude of photoreceptor cells at high yield within a short period of time, without an additional gene transfer. In addition, the differentiated photoreceptor cells are useful in cellular therapy because they, when transplanted into degenerated or injured retinas, can be engrafted and fused within the retinas to prevent or cure retinal degeneration.

Abstract: An electrowetting device which includes a polarizable liquid; and a nonpolar solution separated from the polarizable liquid by an interface. The polarizable liquid may include a polar solvent, an organic acid, and ammonium hydroxide having at least one alkyl group.

Abstract: The pen holder includes a first, second and third cover portions, a connecting part and a fixing unit. The first, second and third cover portions are respectively inserted into a thumb, a forefinger and a middle finger. The connecting part connects the first, second and third cover portions. A first end of the connecting part is fixed to one of the first, second and third cover portions. A force is applied to a second end of the connecting part such that the first, second and third cover portions are closed to each other. A fixing unit fixes to the second end of the connecting part and applies the force to the connecting part.

Abstract: A light emitting device comprising a photonic crystal structure having a crystal structure in which nanospheres are densely arranged in a 3D manner, wherein the nanospheres have phosphors excited by an excitation source to emit light of a wavelength longer than a pump photon of the excitation source, wherein the photonic crystal structure has at least a photonic bandgap (PBG) along a specific crystal orientation, and wherein the wavelength of the pump photon overlaps a photonic bandedge region.

Abstract: A method and apparatus for operating a UE and a BS to perform contention-based scheduling of downlink signal transmissions are disclosed. The method includes receiving, from at least one of BSs adjacent to the UE, a channel carrying inter-BS contention information for downlink signal transmission in an (n+1)th time unit, n being an integer, broadcasting to the BSs a contention number with a highest priority level among contention numbers extracted from the inter-BS contention information, and receiving a downlink signal from a BS that transmitted inter-BS contention information related to the contention number with the highest priority level in the (n+1)th time unit.

Abstract: The present disclosure relates to the ssRNA-specific ribonuclease activity of SAMHD1 (sterile alpha motif (SAM) domain and HD domain-containing protein 1) and its use. It is noteworthy that SAMHD1 has dual catalytic functions which are ribonuclease activity and dNTPase activity: however unlike the dNTPase activity, the ribonuclease activity of SAMHD1 did not require the cofactor dGTP. The present invention can be employed to degrade viral genomic ssRNA and to prevent or treat a ssRNA viral infection.

Abstract: There is provided a system for recommending a TV program based on content, the system including: a terminal device configured to: decode and output a received broadcast stream; extract affectors by analyzing a video that is being played by the video player; estimate affects that are an implicit response of a viewer of the video; and learn a preference model using an affect matching each of the affectors and transmit the learned preference model to a recommendation server, and a recommendation server configured to: in response to receipt of a preference model, estimate real-time preference by applying the preference model to each of the plurality of channels in real time; and register a specific TV program in a recommendation list and transmit the recommendation list to the terminal device in a case where a real-time preference for the specific TV program is equal to or greater than a predetermined level.

Abstract: The present invention relates to a method for separating nanoparticles and analyzing a biological substance using a microfluidic chip. The microfluidic chip of the present invention is effective in more sensitively and precisely detecting an analyte. According to the present invention, the use of the microfluidic chip enables the separation of nanoparticles through separation holes on the basis of size, achieving highly reliable analysis of a biological substance. In conclusion, the microfluidic chip of the present invention uses separation holes adapted to the size of nanoparticles to greatly increase the reliability of analysis of a biological substance, which will contribute to a marked improvement in the reliability of analysis based on microfluidics and a microfluidic system.

Abstract: Disclosed are a high-capacity negative electrode active material and a lithium secondary battery including the same. More particularly, the negative electrode active material includes 50 wt % or more of an alkali metavanadate based on the total weight of a negative electrode active material, wherein the alkali metavanadate has a crystalline phase or an amorphous phase, and a composition of formula AVO3.

Abstract: A particulate sensor apparatus may include an exhaust line through which exhaust gas flows, and a sensor that may be disposed at one side in the exhaust line and generates electrical charges when a particulate passes near vicinity of the sensor, wherein an electrode portion may be formed on a front surface of the sensor facing the particulate.

Abstract: A hyper-branched polymer, which is a product obtained by performing condensation polymerization reaction of a hyper-branched polymer composition including a diisocyanate-based compound and a dihydroxyamine-based compound, a cross-linked hyper-branched polymer, an electrode and electrolyte membrane for a fuel cell including the hyper-branched polymer or the cross-linked hyper-branched polymer, and a fuel cell including the electrode and the electrolyte membrane.

Abstract: Disclosed is an underwater robot based on flapping comprising: an actuator including a smart material and directional material, wherein the smart material is changed in its shape according to an external signal, and the directional material restricts a deformation in a specific direction; a body connected with the actuator; and a controller which makes the actuator perform a first stroke in a direction, and a second stroke in another direction being different from that of the first stroke; wherein the actuator performs at least one deformation of bending and twisting according to position of the smart material and directionality of the directional material, and furthermore enables to simultaneously perform the smooth bending and twisting motion with the simple structure by adjusting the position of the smart material functioning as the active component, and the directionality of the directional material functioning as the passive component.

Abstract: The present invention provides a light-emitting element comprising: a carbon layer comprising a graphene; a plurality of fine structures having grown toward the upper side of the carbon layer; a thin film layer for coating the fine structures; and a light-emitting structure layer formed on the thin film layer.

Abstract: The present invention is about a pharmaceutical composition, an oral preparation, and an injection preparation containing a G protein-coupled Receptor19 (GPCR19) agonist, specifically sodium taurodeoxycholate (HY2191) and its derivative, as an active ingredient for preventing or treating allergic skin diseases. The present invention is also about an external preparation and a cosmetic composition containing said pharmaceutical composition for preventing and improving allergic skin diseases. The said pharmaceutical composition shows an excellent efficacy in treating and improving allergic dermatitis compared with the steroid ointments or immunosuppressive ointments currently used. The said pharmaceutical composition reduces the level of serum IgE, which is a major factor causing allergic dermatitis, increases TH1 cytokine alleviating allergic dermatitis and reduces TH2 cytokine that exacerbates allergic dermatitis.

Abstract: A thin film transistor includes a gate electrode configured to receive a control voltage, a source electrode insulated from the gate electrode, and configured to receive an input voltage, a drain electrode insulated from the gate electrode, and configured to receive an output voltage, at least two carbon nanotube patterns formed in a channel region between the source electrode and the drain electrode, wherein the carbon nanotube patterns are separated from each other, and at least one floating electrode connecting the two carbon nanotube patterns to each other.

Abstract: Disclosed is a formulation for coating a medical device which comprises an anti-scarring agent and a biocompatible polymer for regulating the release of the anti-scarring agent, wherein the mass ratio of the biocompatible polymer to the anti-scaring agent is from 100:15 to 100:0 in which 0 is not included. The present formulation can be advantageously used for coating medical devices for a sustained release of the agents from the device, thus effectively minimizing or preventing the formation of scar tissues resulted from the use of implantable and non-implantable medical devices.

Abstract: The present invention provides a method and apparatus for performing device-to-device communication in a wireless communication system. The method includes generating identification information of a D2D user equipment that supports the D2D communication as identification information for D2D discovery using a hash function, the identification information for discovery includes information of a first length for indicating a division region of the beacon signals and information of a second length included in the beacon. The information of a first length and the information of a second length are smaller than identification information of the D2D user equipment. Accordingly, by performing discovery for the D2D user equipment through the identification information having shorter length than prior art, and performing discovery in a range where the discovery is available through the region in which the beacon signals are allocated, advantages of performing the D2D discovery effectively are provided.

Abstract: The present invention provides a method and an apparatus for performing a device-to-device (D2D) communication service in a wireless communication system. More particularly, D2D terminals supporting D2D communication are identified, discovery groups are formed for the D2D terminals using the same application, and a discovery timing is established depending on the discovery group, wherein the D2D terminals belonging to the same discovery group are shifted to an active state during the discovery timing so as to transreceive signals by using time and frequency resources designated for D2D discovery, wherein the discovery timing is set so as to have a variable value depending on the discovery group.

Abstract: The present invention relates to a novel epitope of IP-10 (IFN-?-inducible protein 10), to an antibody to the epitope or an antigen-binding fragment thereof, to a composition comprising the epitope as an active ingredient for inducing an antibody to IP-10, and to a pharmaceutical composition comprising the antibody or the antigen-binding fragment thereof for preventing or treating diseases relating to IP-10. The anti-IP-10 antibody of the present invention can be effectively used in preventing or treating various diseases relating to IP-10 such as multiple sclerosis, rheumatoid arthritis and systemic lupus erythematosus.

Abstract: The present invention relates to a biodegradable polysorbitol-based osmotically active transporter (PSOAT) and gene therapy using the same as a gene carrier. The biodegradable polysorbitol-based osmotically active transporter (PSOAT) of the present invention includes a sorbitol skeleton, which imparts an osmotic pressure to the cell membrane to improve membrane permeability, thereby exhibiting remarkably improved transfection efficiency. Further, the polysorbitol-based osmotically active transporter of the present invention exhibits high DNA binding ability, effectively protects DNA from nuclease, exhibits physicochemical properties suitable for use as a gene carrier, and has very low cytotoxicity in vitro and in vivo, thereby capable of being used as a gene carrier for gene therapy.